Ethical and legal implications of whole genome and whole exome sequencing in African populations

BMC Medical Ethics 14 (1):21 (2013)
  Copy   BIBTEX

Abstract

Rapid advances in high throughput genomic technologies and next generation sequencing are making medical genomic research more readily accessible and affordable, including the sequencing of patient and control whole genomes and exomes in order to elucidate genetic factors underlying disease. Over the next five years, the Human Heredity and Health in Africa (H3Africa) Initiative, funded by the Wellcome Trust (United Kingdom) and the National Institutes of Health (United States of America), will contribute greatly towards sequencing of numerous African samples for biomedical research

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 107,248

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Support for Full Disclosure Up Front.Felicitas Holzer & Ignacio Mastroleo - 2015 - Hastings Center Report 45 (1):3-3.
Regulation of Next Generation Sequencing.Gail H. Javitt & Katherine Strong Carner - 2014 - Journal of Law, Medicine and Ethics 42 (s1):9-21.

Analytics

Added to PP
2013-05-29

Downloads
225 (#123,238)

6 months
25 (#140,233)

Historical graph of downloads
How can I increase my downloads?